Dna Damage Response Impairment Pathway is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The DNA damage response (DDR) pathway is a critical cellular defense mechanism that detects, signals, and repairs various forms of DNA damage. In neurodegenerative diseases, progressive impairment of DNA repair systems leads to accumulation of genomic damage, cellular dysfunction, and ultimately neuronal death.
Neurons are particularly vulnerable to DNA damage due to their:
- High metabolic rate and oxidative phosphorylation, generating reactive oxygen species (ROS)
- Post-mitotic state meaning DNA damage cannot be replicated and passed to daughter cells
- Long lifespan requiring maintenance over decades
- High oxygen consumption increasing susceptibility to oxidative stress
The DDR involves multiple overlapping repair pathways that become progressively impaired in aging and neurodegenerative diseases.
flowchart TD
A[Oxidative DNA Damage<br/>8-oxoG, Single-strand breaks] --> B[Base Excision Repair<br/>BER] -->
A --> C[Nucleotide Excision Repair<br/>NER] -->
D[Double-strand Breaks<br/>Ionizing radiation, ROS] --> E[Non-Homologous End Joining<br/>NHEJ] -->
D --> F[Homologous Recombination<br/>HR] -->
B --> G[Checkpoint Activation<br/>ATM, ATR, p53] -->
C --> G
E --> G
F --> G
G --> H[DNA Repair Gene Expression<br/>Transcription Activation] -->
H --> I[Cell Cycle Arrest<br/>or Apoptosis] -->
J[DNA Repair Gene Polymorphisms<br/>XRCC1, OGG1, MUTYH] --> K[Neuronal Vulnerability] -->
L[Aging: Cumulative DNA Damage] --> K
K --> M[Neurodegeneration]
style A fill:#ffcccc
style K fill:#ff6666
style M fill:#cc0000
BER handles small, non-bulky lesions including:
- Oxidative damage: 8-oxoguanine (8-oxoG), apurinic/apyrimidinic (AP) sites
- Single-strand breaks: via ROS or spontaneous hydrolysis
- Alkylation damage: from cellular metabolism
Key enzymes:
| Enzyme |
Function |
Neurodegeneration Association |
| OGG1 |
8-oxoG glycosylase |
AD polymorphisms, reduced activity |
| MUTYH |
Adenine glycosylase |
PD variants |
| XRCC1 |
Scaffold protein |
AD risk factor |
| PARP1 |
Poly-ADP ribose polymerase |
Overactivation in AD/PD/ALS |
| DNA Pol β |
Gap-filling polymerase |
Impaired in AD |
| Ligase III |
DNA ligation |
Reduced in aging |
NER removes bulky, helix-distorting lesions:
- UV-induced lesions: cyclobutane pyrimidine dimers, 6-4 photoproducts
- Chemical adducts: from environmental toxins
- Oxidative lesions: bulky 8-oxoG lesions
Two NER subpathways:
- Global genome NER (GG-NER): repairs lesions throughout the genome
- Transcription-coupled NER (TC-NER): prioritizes actively transcribed genes
| Enzyme |
Function |
Disease Association |
| XPA |
Lesion verification |
Reduced in AD |
| XPC |
Global genome recognition |
Parkinson's disease |
| CSA/CSB |
Transcription coupling |
Cockayne syndrome |
| XPG |
3' incision |
Accelerated aging |
| XPF-ERCC1 |
5' incision |
ALS risk |
¶ Double-Strand Break (DSB) Repair
DSBs are the most cytotoxic DNA lesions, repaired via two pathways:
Non-Homologous End Joining (NHEJ):
- Fast, error-prone pathway
- Ligates DNA ends directly
- Ku70/Ku80 heterodimer recruits DNA-PKcs
- Ligase IV completes joining
Homologous Recombination (HR):
- Error-free, uses sister chromatid as template
- Activated in S/G2 phases
- BRCA1/2, RAD51 critical for repair
| Pathway |
Key Proteins |
Disease Relevance |
| NHEJ |
Ku70, Ku80, DNA-PKcs, Ligase IV |
ALS: DNA-PKcs deficiency |
| HR |
BRCA1, BRCA2, RAD51, PALB2 |
Aging, cancer risk |
MMR corrects replication errors:
- Base-base mismatches
- Insertion/deletion loops
- Recognized by MSH2/MSH6 and MLH1/PMS2
Implicated in:
- Huntington's disease (mutant HTT affects MMR)
- ALS (TDP-43 affects MMR proteins)
DNA damage accumulation is a hallmark of AD:
Key findings:
- Elevated 8-oxoG levels in AD brain (2-3x controls)
- Reduced OGG1 activity and expression
- XRCC1 polymorphisms associated with increased AD risk
- PARP1 overactivation depletes NAD+ and ATP
- TET enzymes show altered expression affecting DNA methylation
Pathogenesis cascade:
flowchart LR
A[Aβ Generation] --> B[ROS Production] -->
B --> C[Oxidative DNA Damage] -->
C --> D[BER Impairment] -->
D --> E[PARP Overactivation] -->
E --> F[NAD+ Depletion] -->
F --> G[Energy Failure] -->
G --> H[Neuronal Death] -->
C --> I[Tau Hyperphosphorylation)
I --> H
DNA repair gene associations in AD:
| Gene |
Variant |
Effect |
| OGG1 |
rs1052134 (Ser326Cys) |
Reduced activity |
| XRCC1 |
rs1799782, rs25487 |
Impaired BER |
| PARP1 |
rs1136410 |
Altered activity |
| TET2 |
Various |
Altered methylation |
PD shows selective vulnerability linked to DNA repair:
Key findings:
- MUTYH variants increase PD risk (OR ~2-3)
- OGG1 polymorphisms associated with sporadic PD
- XPC variants affect repair capacity
- Mitochondrial DNA more vulnerable than nuclear
Mitochondrial DNA damage in PD:
- Complex I deficiency leads to ROS
- 8-oxoG accumulates in substantia nigra
- Mitochondrial BER (mtBER) impaired
- PINK1/Parkin affect mitochondrial DNA repair
Pathogenesis cascade:
flowchart LR
A[MTDNA Damage] --> B[8-oxoG Accumulation] -->
B --> C[Mitochondrial Dysfunction)
C --> D[ROS Production] -->
D --> A
E[Nuclear DNA Damage] --> F[Cellular Stress Response] -->
F --> G[α-Synuclein Aggregation] -->
G --> H[DA Neuron Death]
DNA repair gene associations in PD:
| Gene |
Variant |
Effect |
| MUTYH |
rs3210092, rs3219216 |
PD risk |
| OGG1 |
rs1052134 |
PD susceptibility |
| XRCC1 |
rs25487 |
Reduced repair |
| XPC |
rs2228001 |
Impaired NER |
ALS shows pronounced DNA repair deficits:
Key findings:
- DNA-PKcs activity reduced in ALS motor neurons
- TDP-43 aggregation affects DNA repair gene expression
- C9orf72 expansions cause RNA foci affecting repair
- PARP overactivation in ALS models
- Reduced HR capacity in ALS patients
Pathogenesis cascade:
flowchart LR
A[TDP-43 Aggregation] --> B[DNA Repair Gene Dysregulation] -->
B --> C[DSB Accumulation] -->
C --> D[Genomic Instability] -->
D --> E[Motor Neuron Death] -->
F[C9orf72 Expansion] --> G[RNA Foci Formation] -->
G --> B
DNA repair gene associations in ALS:
| Gene |
Variant/Change |
Effect |
| DNA-PKcs |
Activity reduced |
Impaired NHEJ |
| PARP1 |
Overactivation |
Energy depletion |
| XRCC1 |
Polymorphisms |
Risk factor |
| FUS |
Mutations |
RNA processing |
HD shows DNA repair alterations:
Key findings:
- Mutant huntingtin affects DNA repair protein localization
- DNA damage accumulation in striatal neurons
- Impaired BER capacity
- Altered checkpoint signaling
DNA repair gene associations in HD:
| Gene |
Finding |
Mechanism |
| PARP1 |
Overactivation |
mHtt sequesters PARP |
| XRCC1 |
Reduced |
Altered expression |
| MSH2/MSH3 |
Altered |
Affects somatic instability |
¶ Aging and Cumulative DNA Damage
The DNA damage theory of aging posits that:
- Cumulative DNA damage causes cellular senescence
- Repair capacity declines with age
- Accumulated mutations affect tissue function
Age-related changes in DNA repair:
- BER efficiency declines ~30-50% by age 70
- NHEJ becomes less accurate
- Checkpoint responses weaken
- Telomere attrition adds to genomic stress
- Olaparib, Rucaparib, Niraparib
- Prevent NAD+ depletion
- Under investigation for AD/PD
- Caution: May affect DNA repair in dividing cells
- CoQ10: Protects against oxidative DNA damage
- Vitamin E: Reduces lipid peroxidation
- N-acetylcysteine: Glutathione precursor
- MitoQ: Mitochondria-targeted antioxidant
- Small molecule BER activators
- Checkpoint kinase inhibitors (for cancer, not neurodegeneration)
- NAD+ precursors (nicotinamide riboside, nicotinamide mononucleotide)
- OGG1 delivery: Restore 8-oxoG repair
- PARP1 modulation: Reduce overactivation
- Mitochondrial-targeted DNA repair enzymes
- Caloric restriction improves DNA repair
- Exercise enhances BER capacity
- UV protection reduces NER burden
| Biomarker |
Source |
Disease |
Significance |
| 8-oxo-dG |
CSF, Plasma |
AD, PD |
Oxidative stress marker |
| γH2AX |
Blood |
ALS |
DSB accumulation |
| PAR levels |
Blood |
AD, PD |
PARP activation |
| XRCC1 |
Blood |
AD |
Repair capacity |
- PET imaging of PARP activation (under development)
- Comet assay for peripheral blood cells
The study of Dna Damage Response Impairment Pathway has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Weissman L, et al. (2007). "DNA damage, mitochondrial dysfunction, and synaptic deficits in the hippocampus of aged mice." J Bioenerg Biomembr 39(1): 73-82. PMID:17354034
- Nakabeppu Y, et al. (2007). "The repair of 8-oxoguanine in mitochondrial DNA and its involvement in neurodegeneration." Antioxid Redox Signal 9(9): 1401-1410. PMID:17696745
- Coppedè F, et al. (2014). "The role of mutations in DNA repair genes in amyotrophic lateral sclerosis." Pharmacogenomics 15(9): 1205-1214. PMID:25155900
- Martin LJ, et al. (2015). "DNA oxidation in Alzheimer's disease and ALS." Brain Res 1628: 273-282. PMID:26048472
- Hegde ML, et al. (2013). "Emerging links between base excision DNA repair deficiency and neurodegenerative diseases." DNA Repair 17: 55-73. PMID:24704612
- Sampath H, et al. (2011). "Oxidative DNA damage in Huntington's disease." Adv Exp Med Biol 701: 77-84. PMID:21143979
- Chen D, et al. (2019). "PARP inhibition: a promising therapeutic target in ALS." Neuropharmacology 145: 1-10. PMID:30465735
- Jęśko H, et al. (2020). "DNA damage and repair in neurodegenerative diseases." Neural Regen Res 15(2): 255-262. PMID:31531664
- Kim J, et al. (2017). "MUTYH-associated Parkinson's disease." J Neural Transm 124(10): 1177-1184. PMID:28589579
- Katyal S, et al. (2014). "DNA damage and neurodegeneration." Ageing Res Rev 18: 3-14. PMID:25219766
🟡 Moderate Confidence
| Dimension |
Score |
| Supporting Studies |
10 references |
| Replication |
67% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 41%